Univariatea | Multivariateb | ||||||
---|---|---|---|---|---|---|---|
N | 5-year RFSc | P-value | HRd | 95% CIe | P-value | ||
Sex | Male | 61 | 46.1% | 0.577 | 1.20 | 0.63–2.31 | 0.581 |
Female | 36 | 36.0% | |||||
Age | <65 | 46 | 42.2% | 0.824 | 1.39 | 0.76–2.53 | 0.285 |
≥65 | 51 | 41.9% | |||||
Tumor major axis(mm) | ≥90 | 33 | 30.8% | 0.092 | 1.46 | 0.71–3.21 | 0.109 |
<90 | 64 | 48.8% | |||||
T-stage | T4 | 70 | 38.9% | 0.326 | 1.46 | 0.79–3.63 | 0.311 |
T2/ T3 | 27 | 50.1% | |||||
N-stage | N3 | 50 | 33.4% | 0.339 | 1.51 | 0.82–2.84 | 0.187 |
N1/ N2 | 47 | 50.9% | |||||
Venous invasion | Present | 48 | 36.5% | 0.034 | 1.82 | 1.01–3.37 | 0.048 |
Absent | 49 | 47.4% | |||||
Lymphatic invasion | Present | 87 | 39.8% | 0.168 | 1.51 | 0.56–5.28 | 0.445 |
Absent | 10 | 40.0% |